Overview

Intensive 7-day Treatment for PTSD Combining Ketamine With Exposure Therapy

Status:
Active, not recruiting
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to combine a single infusion of Ketamine with 7-days of trauma focus psychotherapy to relieve post traumatic stress disorder (PTSD) symptoms more effectively. This treatment has the potential to produce a significant therapeutic effect that otherwise would take months to occur.
Phase:
Phase 2
Details
Lead Sponsor:
Yale University
Treatments:
Ketamine
Midazolam